–
Статьи в журналах
-
- 2021 A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
- Brose Marcia S., Panaseykin Yury, Konda Bhavana, de la Fouchardiere Christelle, Hughes Brett G.M., Gianoukakis Andrew G., Park Young Joo, Romanov Ilia, Krzyzanowska Monika K., Leboulleux Sophie, Binder Terri A., Dutcus Corina, Xie Ran, Taylor Matthew H.
- в журнале Journal of Clinical Endocrinology and Metabolism, издательство The Endocrine Society (United States), том 107, № 3, с. 776-787 DOI